Biotech · Private company · Pleasanton, CA, US
Noctrix Health, Inc.
Track this companyFree. Adds Noctrix Health, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials83 recruiting or active
Pipeline programs11From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline11
- Investigational Extended Duration (XD-) TOMAC TherapyRestless Legs Syndrome (RLS)ClinicalTrials.gov · fetched Nov 12, 2026
- Investigational Noninvasive Neuromodulation DeviceRestless Legs SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- Noctrix Health NPNS device v1.0 - ActiveRestless Legs SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- Noctrix Health NPNS device v1.0 - ShamRestless Legs SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- Noninvasive Peripheral Nerve Stimulation (NPNS)Restless Legs SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- NTX100Restless Legs SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- NTX100 Neuromodulation SystemRestless Legs SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- NTX100 Neuromodulation System - ActiveRestless Legs SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- NTX100 Neuromodulation System - Open-LabelRestless Legs SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- NTX100 Neuromodulation System - ShamRestless Legs SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- Tonic Motor Activation (TOMAC) TherapyRestless Legs Syndrome (RLS)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials8
- Optimizing Extended-Duration (XD-) TOMAC Therapy for Restless Legs Syndrome (RLS)NA · RECRUITING · started Jun 8, 2026ClinicalTrials.gov NCT07675109 · fetched Nov 12, 2026
- Response to an Investigational Device in Patients With Restless Legs SyndromeNA · ACTIVE_NOT_RECRUITING · started Mar 11, 2025ClinicalTrials.gov NCT06866132 · fetched Nov 12, 2026
- A Post-Market Study for Long-Term Effectiveness and Safety of the TOMAC System for RLSACTIVE_NOT_RECRUITING · started Nov 15, 2023ClinicalTrials.gov NCT06076499 · fetched Nov 12, 2026
- Noninvasive Peripheral Nerve Stimulation for Medication-Naive and Medication-Refractory RLSNA · COMPLETED · started Mar 8, 2022ClinicalTrials.gov NCT05214963 · fetched Nov 12, 2026
- Extension Study Evaluating NTX100 Neuromodulation System for Medication-Refractory Primary RLSNA · COMPLETED · started Dec 20, 2021ClinicalTrials.gov NCT05196828 · fetched Nov 12, 2026
- Noninvasive Peripheral Nerve Stimulation for Medication-Refractory Primary RLS (The RESTFUL Study)NA · COMPLETED · started May 6, 2021ClinicalTrials.gov NCT04874155 · fetched Nov 12, 2026
- Noninvasive Peripheral Nerve Stimulation for Restless Legs Syndrome During Opioid Medication ReductionNA · COMPLETED · started Apr 6, 2021ClinicalTrials.gov NCT04698343 · fetched Nov 12, 2026
- Noninvasive Peripheral Nerve Stimulation for Restless Legs SyndromeNA · COMPLETED · started Jul 14, 2019ClinicalTrials.gov NCT04700683 · fetched Nov 12, 2026
NIH awards2
- Developing closed-loop tonic motor activation therapy for treatment of refractory restless legs syndromeFiscal year 2026 · $1.3MNIH RePORTER 5R44NS117294-05 · fetched Nov 12, 2026
- Developing closed-loop tonic motor activation therapy for treatment of refractory restless legs syndromeFiscal year 2025 · $515.5KNIH RePORTER 2R44NS117294-04 · fetched Nov 12, 2026